News | March 18, 2021
Merck accelerates expansion plans for single-use products critical to manufacturing vaccines
The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.
The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.
The vaccine was 85 percent effective in preventing severe disease across all regions.
A mix of favorable government policies and a positive environment will create a win-win situation for all stakeholders
The medical device Sector in India suffers from a considerable cost of manufacturing disability.
This vaccination programme is based on the principles of priority groups to be vaccinated and health care workers both in the government and private sectors including ICDS workers will receive the vaccine during this phase.
Their feedback and the consequent changes in software/protocols based on those inputs were deliberated upon.
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
Subscribe To Our Newsletter & Stay Updated
